Literature DB >> 19845667

Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial.

A B Kimball1, J R Kaczvinsky, J Li, L R Robinson, P J Matts, C A Berge, K Miyamoto, D L Bissett.   

Abstract

BACKGROUND: Topical niacinamide and N-acetyl glucosamine (NAG) each individually inhibit epidermal pigmentation in cell culture. In small clinical studies, niacinamide-containing and NAG-containing formulations reduced the appearance of hyperpigmentation.
OBJECTIVES: To assess the effect of a combination of niacinamide and NAG in a topical moisturizing formulation on irregular facial pigmentation, including specific detection of changes in colour features associated with melanin.
METHODS: This was a 10-week, double-blind, vehicle-controlled, full-face, parallel-group clinical study conducted in women aged 40-60 years. After a 2-week washout period, subjects used a daily regimen of either a morning sun protection factor (SPF) 15 sunscreen moisturizing lotion and evening moisturizing cream each containing 4% niacinamide + 2% NAG (test formulation; n = 101) or the SPF 15 lotion and cream vehicles (vehicle control; n = 101). Product-induced changes in apparent pigmentation were assessed by capturing digital photographic images of the women after 0, 4, 6 and 8 weeks of product use and evaluating the images by algorithm-based computer image analysis for coloured spot area fraction, by expert visual grading, and by chromophore-specific image analysis based on noncontact SIAscopy for melanin spot area fraction and melanin chromophore evenness.
RESULTS: By all four measures, the niacinamide + NAG formulation regimen was significantly (P < 0.05) more effective than the vehicle control formulation regimen in reducing the detectable area of facial spots and the appearance of pigmentation.
CONCLUSIONS: A formulation containing the combination of niacinamide + NAG reduced the appearance of irregular pigmentation including hypermelaninization, providing an effect beyond that achieved with SPF 15 sunscreen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845667     DOI: 10.1111/j.1365-2133.2009.09477.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

2.  In vitro-in vivo correlation in skin permeation.

Authors:  D Mohammed; P J Matts; J Hadgraft; M E Lane
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

3.  N-acetyl glucosamine obtained from chitin by chitin degrading factors in Chitinbacter tainanesis.

Authors:  Jeen-Kuan Chen; Chia-Rui Shen; Chao-Hsien Yeh; Bing-Shiun Fang; Tung-Li Huang; Chao-Lin Liu
Journal:  Int J Mol Sci       Date:  2011-02-17       Impact factor: 5.923

Review 4.  Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention.

Authors:  Luca Fania; Cinzia Mazzanti; Elena Campione; Eleonora Candi; Damiano Abeni; Elena Dellambra
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

5.  Intralesional cryotherapy with triamcinolone and onabotulinumtoxinA injections for umbilical keloid: A case report.

Authors:  Jennifer Vh Tran; Shantel Dj Lultschik; Sheetal Sapra; Kevin Dong; Klaudija Gusic; Matthew Goldstein
Journal:  Scars Burn Heal       Date:  2021-12-21

Review 6.  Update on Melasma-Part II: Treatment.

Authors:  Daniel P Cassiano; Ana Cláudia C Espósito; Carolina N da Silva; Paula B Lima; Joana A F Dias; Karime Hassun; Luciane D B Miot; Hélio A Miot; Ediléia Bagatin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-29

7.  Cosmeceuticals for Hyperpigmentation: What is Available?

Authors:  Rashmi Sarkar; Pooja Arora; K Vijay Garg
Journal:  J Cutan Aesthet Surg       Date:  2013-01

Review 8.  Melasma: an Up-to-Date Comprehensive Review.

Authors:  Oluwatobi A Ogbechie-Godec; Nada Elbuluk
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.